Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Sell
11,348
-255
-2% -$406K 0.49% 45
2026
Q1
$15.3M Sell
11,603
-77
-0.7% -$106K 0.38% 62
2025
Q4
$12.5M Sell
11,680
-69
-0.6% -$72K 0.31% 80
2025
Q3
$11.4M Buy
11,749
+9,607
+449% +$7.55M 0.3% 85
2025
Q2
$1.72M Buy
2,142
+376
+21% +$270K 0.05% 333
2025
Q1
$1.17M Sell
1,766
-691
-28% -$503K 0.04% 360
2024
Q4
$1.7M Buy
+2,457
New +$1.76M 0.06% 298

Other funds holding ASML

Cary Street Partners's ASML Position: Q2 2026 in Review

Cary Street Partners reduced its ASML (ASML) stake by 2.2% in Q2 2026, selling an estimated $406K and leaving 11,348 shares worth $22.6M. The position accounts for 0.49% of the portfolio, ranked #45.

Cary Street Partners first reported a position in ASML in Q4 2024 and has held it in 7 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Cary Street Partners held 11,348 shares of ASML worth $22.6M as of Q2 2026.
  • Cary Street Partners sold 255 ASML shares in Q2 2026, an estimated $406K.
  • ASML made up 0.49% of Cary Street Partners's portfolio in Q2 2026, its #45 holding.
  • Cary Street Partners first reported a position in ASML in Q4 2024 and has held it in 7 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.